ClinicalTrials.Veeva
Menu

Find clinical trials for Alzheimer's Disease in Austin, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Alzheimer Disease
Cognitive Dysfunction
Dementia
Mental Disorders
Brain Diseases
Neurodegenerative Diseases
Psychotic Disorders

Alzheimer's Disease trials near Austin, TX, USA:

A Study of Remternetug (LY3372993) in Participants With Alzheimer's Disease (TRAILRUNNER-ALZ 1)

reason for this study is to collect safety and efficacy information regarding the study drug remternetug in participants with early symptomatic Alzheimer's...

Active, not recruiting
Alzheimer's Disease
Drug: Remternetug (SC)
Drug: Placebo

Phase 3

Lilly
Lilly

Austin, Texas, United States and 75 other locations

administered once every four weeks (Q4W) in slowing cognitive and functional decline as compared to placebo in participants with early Alzheimer's...

Active, not recruiting
Alzheimer Disease
Drug: Placebo
Drug: sabirnetug

Phase 2

Acumen Pharmaceuticals

Austin, Texas, United States and 96 other locations

This study will be conducted to evaluate the efficacy of lecanemab in participants with early Alzheimer's disease (EAD) by determin...

Active, not recruiting
Early Alzheimer's Disease
Drug: Placebo
Drug: Lecanemab

Phase 3

Eisai
Eisai

Austin, Texas, United States and 246 other locations

to alleviate symptoms when given to people with mild to moderate Alzheimer Disease (AD) dementia. This is done by looking at partic...

Enrolling
Alzheimer Disease
Drug: Placebo
Drug: Mevidalen

Phase 2

Lilly
Lilly

Austin, Texas, United States and 61 other locations

study is to assess the effectiveness, safety, and tolerability of BMS-986446 an Anti-MTBR Tau Monoclonal Antibody in participants with Early Alzheimer's...

Enrolling
Alzheimer Disease, Early Onset
Other: Placebo
Drug: BMS-986446

Phase 2

Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb (BMS)

Austin, Texas, United States and 204 other locations

Locations recently updated

The main purpose of this study is to evaluate the safety and efficacy of donanemab in participants with preclinical Alzheimer's Disease...

Enrolling
Alzheimer Disease
Drug: Donanemab
Drug: Placebo

Phase 3

Lilly
Lilly

Austin, Texas, United States and 230 other locations

The reason for this study is to see how safe and effective the study drug donanemab is in participants with early Alzheimer's disease...

Active, not recruiting
Alzheimer Disease
Drug: Donanemab
Drug: Placebo

Phase 3

Lilly
Lilly

Austin, Texas, United States and 275 other locations

The purpose of this study is to measure the difference in time to developing or worsening memory, thinking, or functional problems due to Alzheimer's...

Enrolling
Alzheimer's Disease
Drug: Placebo
Drug: Remternetug

Phase 3

Lilly
Lilly

Austin, Texas, United States and 334 other locations

This study is done to find out whether the medicine, semaglutide, has a positive effect on early Alzheimer's disease.Participants w...

Active, not recruiting
Early Alzheimer´s Disease
Drug: Placebo (semaglutide)
Drug: Semaglutide

Phase 3

Novo Nordisk
Novo Nordisk

Austin, Texas, United States of America and 381 other locations

a THC-based (Delta-9-Tetrahydrocannabinol) formulation administered twice a day on Agitation in patients with mild to severe dementia from Alzheimer's...

Enrolling
Alzheimer Disease
NPS
Drug: IGC-AD1-Placebo
Drug: IGC-AD1-Active

Phase 2

IGC Pharma, LLC

Austin, Texas, United States and 19 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems